I-49 free base

CAS No. ——

I-49 free base( Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)- )

Catalog No. M22764 CAS No. ——

I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 357 In Stock
10MG 597 In Stock
25MG 882 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    I-49 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
  • Description
    I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)-
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    SOS1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    482.92
  • Molecular Formula
    C23H26ClF3N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.C[C@@H](Nc1nc(C)nc2cc(=O)n(cc12)C1CCOCC1)c1cccc(c1C)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.RAMHARTER JUERGEN,et al.Novel benzylamino substituted pyridopyrimidinone and derivative as SOS1 inhibitor.TW 201938557 A
molnova catalog
related products
  • Uplarafenib

    Uplarafenib (B-Raf IN 10) is a potent BRAF inhibitor with an IC50 of 50-100 nM. B-Raf IN 10 exhibits antitumor activity that may influence cell proliferation and differentiation, making it suitable for studying solid tumors.

  • RAF-IN-10n

    A highlt potent and selective BRAF/CRAF inhibitor with IC50 of 24/25 nM, respectively.

  • Sorafenib-d3

    Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).